Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,058,997 papers from all fields of science
Search
Sign In
Create Free Account
L 627
Known as:
L-627
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
biapenem
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Pharmacokinetics and Safety of a New Parenteral Carbapenem Antibiotic, Biapenem (L-627), in Elderly Subjects
O. Kozawa
,
Toshihiko Uematsu
,
+8 authors
M. Kanamaru
Antimicrobial Agents and Chemotherapy
1998
Corpus ID: 38542922
ABSTRACT The pharmacokinetics and tolerability of a new parenteral carbapenem antibiotic, biapenem (L-627), were studied in…
Expand
1995
1995
Interactions of biapenem with active-site serine and metallo-beta-lactamases
A. Felici
,
M. Perilli
,
+6 authors
G. Amicosante
Antimicrobial Agents and Chemotherapy
1995
Corpus ID: 36155236
Biapenem, formerly LJC 10,627 or L-627, a carbapenem antibiotic, was studied in its interactions with 12 beta-lactamases…
Expand
1994
1994
[Pharmacokinetic and clinical studies on biapenem (L-627) in the pediatric field].
Y. Toynaga
,
T. Ishihara
,
+4 authors
H. Chiba
The Japanese Journal of Antibiotics
1994
Corpus ID: 32628389
Pharmacokinetic and clinical studies on biapenem (L-627), a newly developed carbapenem, were performed and the following results…
Expand
1994
1994
[Pharmacokinetic, bacteriological and clinical studies on biapenem (L-627) in children].
T. Tajima
,
R. Niimi
,
+6 authors
T. Abe
The Japanese Journal of Antibiotics
1994
Corpus ID: 13229103
The results are summarized as follows: 1. A total of 10 patients were treated with biapenem (L-627). We received informed consent…
Expand
1994
1994
[Effect of biapenem (L-627) on fecal flora in gnotobiotic mice and children].
S. Iwata
,
K. Yamamoto
,
+7 authors
T. Oikawa
The Japanese Journal of Antibiotics
1994
Corpus ID: 43690819
Biapenem (L-627), a novel injectable carbapenem antibiotic, was studied with regard to its effect on mice inoculated with four…
Expand
1994
1994
[Pharmacokinetic, bacteriological and clinical evaluation of biapenem (L-627) in the pediatric field].
N. Iwai
,
H. Nakamura
,
Y. Taneda
The Japanese Journal of Antibiotics
1994
Corpus ID: 26201388
Pharmacokinetic, bacteriological and clinical studies on biapenem (L-627), a newly developed carbapenem antibiotic, were…
Expand
1994
1994
[Clinical evaluation of a new carbapenem antibiotic, biapenem (L-627), in the pediatric field].
H. Meguro
,
R. Fujii
,
+7 authors
T. Toba
The Japanese Journal of Antibiotics
1994
Corpus ID: 19779244
Biapenem (L-627) was evaluated for its safety and efficacy in 27 children with various bacterial infections. L-627 was effective…
Expand
1994
1994
[Bacteriological, pharmacokinetic and clinical studies on biapenem (L-627) in the pediatric field].
T. Motohiro
,
S. Handa
,
+7 authors
S. Imai
The Japanese Journal of Antibiotics
1994
Corpus ID: 31330121
Antibacterial activities were determined and pharmacokinetics and a clinical studies were performed on biapenem (L-627), a novel…
Expand
1993
1993
Phase 1 study of L-627, biapenem, a new parenteral carbapenem antibiotic.
M. Nakashima
,
Toshihiko Uematsu
,
+6 authors
T. Sasaki
International journal of clinical pharmacology…
1993
Corpus ID: 42630962
The safety and pharmacokinetics of L-627, a new injectable carbapenem antibiotic, were evaluated in healthy volunteers. In single…
Expand
1993
1993
Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems.
K. J. Wildonger
,
R. W. Ratcliffe
Journal of antibiotics (Tokyo. )
1993
Corpus ID: 31797561
The syntheses of five thiols, including three dihydropyrrolotriazoliumthiol salts, 1,4-dimethyl-5-mercaptomethyl-1,2,4-triazolium…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE